
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    [{"authors":null,"categories":null,"content":"I‚Äôm now a Postdoctoral Scholar of Genome Sciences at University of Washington. I‚Äôm currently studying the extrachromosomal DNA-chromatin interactions using 3D genome conformation assays, such as ChIA-PET and ChIA-Drop, and integrate these data with Cut \u0026amp; Tag, ChIP-seq and RNA-seq.\n","date":1607817600,"expirydate":-62135596800,"kind":"term","lang":"en","lastmod":1607817600,"objectID":"2525497d367e79493fd32b198b28f040","permalink":"","publishdate":"0001-01-01T00:00:00Z","relpermalink":"","section":"authors","summary":"I‚Äôm now a Postdoctoral Scholar of Genome Sciences at University of Washington. I‚Äôm currently studying the extrachromosomal DNA-chromatin interactions using 3D genome conformation assays, such as ChIA-PET and ChIA-Drop, and integrate these data with Cut \u0026 Tag, ChIP-seq and RNA-seq.","tags":null,"title":"Chia-Hao Tung","type":"authors"},{"authors":[],"categories":null,"content":" Click on the Slides button above to view the built-in slides feature. Slides can be added in a few ways:\nCreate slides using Hugo Blox Builder‚Äôs Slides feature and link using slides parameter in the front matter of the talk file Upload an existing slide deck to static/ and link using url_slides parameter in the front matter of the talk file Embed your slides (e.g. Google Slides) or presentation video on this page using shortcodes. Further event details, including page elements such as image galleries, can be added to the body of this page.\n","date":1906549200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1906549200,"objectID":"a8edef490afe42206247b6ac05657af0","permalink":"https://tungchuw.github.io/talk/example-talk/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/talk/example-talk/","section":"event","summary":"An example talk using Hugo Blox Builder's Markdown slides feature.","tags":[],"title":"Example Talk","type":"event"},{"authors":null,"categories":null,"content":"from IPython.core.display import Image Image(\u0026#39;https://www.python.org/static/community_logos/python-logo-master-v3-TM-flattened.png\u0026#39;) print(\u0026#34;Welcome to Academic!\u0026#34;) Welcome to Academic! Organize your notebooks Place the notebooks that you would like to publish in a notebooks folder at the root of your website.\nImport the notebooks into your site pipx install academic academic import \u0026#39;notebooks/**.ipynb\u0026#39; content/post/ --verbose The notebooks will be published to the folder you specify above. In this case, they will be published to your content/post/ folder.\n","date":1699056000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1699056000,"objectID":"94fa5e486d3bf3e0941e2ff6e7126c06","permalink":"https://tungchuw.github.io/post/blog-with-jupyter/","publishdate":"2023-11-04T00:00:00Z","relpermalink":"/post/blog-with-jupyter/","section":"post","summary":"Easily blog from Jupyter notebooks!","tags":null,"title":"Blog with Jupyter Notebooks!","type":"post"},{"authors":["Xiu‚ÄëRui Hsu","Jia‚ÄëEn Wu","Yi‚ÄëYing Wu","Sheng‚ÄëYen Hsiao","Jui‚ÄëLin Liang","Ya‚ÄëJu Wu","*Chia-Hao Tung*","Meng‚ÄëFan Huang","Ming‚ÄëShiu Lin","Pan‚ÄëChyr Yang","Yuh‚ÄëLing Chen#","Tse‚ÄëMing Hong#"],"categories":null,"content":"","date":1698278400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1698278400,"objectID":"3dab3241ef0ae6554d5b92ac367be651","permalink":"https://tungchuw.github.io/publication/2023-10-26-paper-mleta1/","publishdate":"2023-10-26T00:00:00Z","relpermalink":"/publication/2023-10-26-paper-mleta1/","section":"publication","summary":"**Background:**\nLung cancer is the most common and deadliest cancer worldwide, and approximately 90% of all lung cancer deaths are caused by tumor metastasis. Tumor-derived exosomes could potentially promote tumor metastasis through the delivery of metastasis-related molecules. However, the function and underlying mechanism of exosomal long noncoding RNA (lncRNA) in lung cancer metastasis remain largely unclear.\n**Methods:**\nCell exosomes were purifed from conditioned media by diferential ultracentrifugation and observed using transmission electron microscopy, and the size distributions were determined by nanoparticle tracking analysis. Exosomal lncRNA sequencing (lncRNA-seq) was used to identify long noncoding RNAs. Cell migration and invasion were determined by wound-healing assays, two-chamber transwell invasion assays and cell mobility tracking. Mice orthotopically and subcutaneously xenografted with human cancer cells were used to evaluate tumor metastasis in vivo. Western blot, qRT‚ÄíPCR, RNA-seq, and dual-luciferase reporter assays were performed to investigate the poten‚Äë tial mechanism. The level of exosomal lncRNA in plasma was examined by qRT‚ÄíPCR. MS2-tagged RNA afnity purif‚Äë cation (MS2-TRAP) assays were performed to verify lncRNA-bound miRNAs.\n**Results:**\nExosomes derived from highly metastatic lung cancer cells promoted the migration and invasion of lung cancer cells with low metastatic potential. Using lncRNA-seq, we found that a novel lncRNA, lnc-MLETA1, was upregu‚Äë lated in highly metastatic cells and their secreted exosomes. Overexpression of lnc-MLETA1 augmented cell migra‚Äë tion and invasion of lung cancer. Conversely, knockdown of lnc-MLETA1 attenuated the motility and metastasis of lung cancer cells. Interestingly, exosome-transmitted lnc-MLETA1 promoted cell motility and metastasis of lung cancer. Reciprocally, targeting lnc-MLETA1 with an LNA suppressed exosome-induced lung cancer cell motility. Mechanistically, lnc-MLETA1 regulated the expression of EGFR and IGF1R by sponging miR-186-5p and miR-497-5p to facilitate cell motility. The clinical datasets revealed that lnc-MLETA1 is upregulated in tumor tissues and predicts\n","tags":null,"title":"Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer","type":"publication"},{"authors":["Chia-Hao Tung","Jia-En Wu","Meng-Fan Huang","Wen-Lung Wang","Yi-Ying Wu","Yao-Tsung Tsai","Xiu-Rui Hsu","Sheng-Hsiang Lin","Yuh-Ling Chen","Tse-Ming Hong"],"categories":null,"content":"","date":1695081600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1695081600,"objectID":"e883b056932ddca843dc83a10ff258ae","permalink":"https://tungchuw.github.io/publication/2023-09-19-paper-usp5/","publishdate":"2023-09-19T00:00:00Z","relpermalink":"/publication/2023-09-19-paper-usp5/","section":"publication","summary":"**Background:**\nLung cancer has the highest mortality rate in the world, and mounting evidence suggests that cancer stem cells (CSCs) are associated with poor prognosis, recurrence, and metastasis of lung cancer. It is urgent to identify new biomarkers and therapeutic targets for targeting lung CSCs.\n**Methods:**\nWe computed the single-sample gene set enrichment analysis (ssGSEA) of 1554 Reactome gene sets to identify the mRNA expression-based stemness index (mRNAsi)-associated pathways using the genome-wide RNA sequencing data of 509 patients from The Cancer Genome Atlas (TCGA) cohort of lung adenocarcinoma (LUAD). Phenotypic effects of ubiquitin-specific peptidase 5 (USP5) on the CSC-like properties and metastasis were examined by in vitro sphere formation assay, migration assay, invasion assay, and in vivo xenografted animal models. Cycloheximide chase assay, co-immunoprecipitation assay, and deubiquitination assay were performed to confirm the effect of USP5 on the deubiquitination of Œ≤-catenin.\n**Results:**\nWe demonstrated that USP5 expression were positively correlated with the stemness-associated signatures and poor outcomes in lung cancer specimens. Silencing of endogenous USP5 reduced CSC-like characteristics, epithelial-mesenchymal transition (EMT), and metastasis in vitro and in vivo. Furthermore, USP5 interacted with Œ≤-catenin, which resulted in deubiquitination, stabilization of Œ≤-catenin, and activation of Wnt/Œ≤-catenin pathway. Accordingly, expression of USP5 was positively correlated with the enrichment score of the Wnt/TCF pathway signature in human lung cancer. Silencing of Œ≤-catenin expression suppressed USP5-enhancing sphere formation. Targeting USP5 with the small molecule WP1130 promoted the degradation of Œ≤-catenin, and showed great inhibitory effects on sphere formation, migration, and invasion. Finally, we identified a poor-prognosis subset of tumors characterized by high levels of USP5, Wnt signaling score, and Stemness score in both TCGA-LUAD and Rousseaux_2013 datasets.\n**Conclusions:**\nThese findings reveal a clinical evidence for USP5-enhanced Wnt/Œ≤-catenin signaling in promoting lung cancer stemness and metastasis, implying that targeting USP5 could provide beneficial effects to improve lung cancer therapeutics.\n","tags":null,"title":"Ubiquitin-specific peptidase 5 facilitates cancer stem cell-like properties in lung cancer by deubiquitinating Œ≤-catenin","type":"publication"},{"authors":["Sheng-Yen Hsiao","Shang-Mei Weng","Jenn-Ren Hsiao","Jia‚ÄëEn Wu","Yi‚ÄëYing Wu","*Chia-Hao Tung*","Wan-Lin Shen","Shu-Fang Sun","Wen-Tsung Huang","Cheng-Yao Lin","Shang-Hung Chen","Yuh‚ÄëLing Chen#","Tse‚ÄëMing Hong#","Jang-Yang Chang#"],"categories":null,"content":"","date":1675382400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1675382400,"objectID":"a5eefc155a38d111b75fc3bd7e1dcc28","permalink":"https://tungchuw.github.io/publication/2023-02-03-paper-mir455/","publishdate":"2023-02-03T00:00:00Z","relpermalink":"/publication/2023-02-03-paper-mir455/","section":"publication","summary":"**Background:**\nLymph node and distant metastasis contribute to poor outcomes in patients with oral squamous cell carcinoma (OSCC). The mechanisms regulating cancer migration and invasion play a key role in OSCC.\n**Methods:**\nWe determined migration and invasion ability of OSCC by wound-healing assay, two-chamber transwell invasion assay and cell mobility tracking and evaluated tumor metastasis in vivo. Western blot (WB), qRT-PCR, RNA-seq, dual-luciferase reporter assays and nuclear/cytoplasmic fractionation were performed to investigate the potential mechanism. Immunohistochimical (IHC) staining determined vimentin and PDZK1IP1 expression in OSCC tissues.\n**Results and conclusions:**\nIn this study, we determined that miR-455-5p was associated with lymph node metastasis and clinical invasion, leading to poor outcomes in patients with OSCC. MiR-455-5p promoted oral cancer cell migration and invasion and induced epithelial-to-mesenchymal transition (EMT). We also identified a new biomarker, PDZK1IP1 (MAP17), that was targeted by miR-455-5p. PDZK1IP1 knockdown led to migration, metastasis, EMT, and increased transforming growth factor-Œ≤ signaling in OSCC. In addition, miR-455-5p overexpression and PDZK1IP1 inhibition promoted collective OSCC cell migration. According to data from the Cancer Genome Atlas database and the NCKU-OrCA-40TN data set, miR-455-5p and PDZK1IP1 are positively and negatively correlated, respectively, with partial EMT score. High miR-455-5p expression was associated with high vimentin levels and low MAP17 H-scores. The patients with low MAP17 expression had higher rates of disease recurrence than did patients with high MAP17 expression, especially for patients with clinical invasion risk factors and low MAP17 expression. These results suggest that miR-455-5p suppresses PDZK1IP1 expression and mediates OSCC progression. MiR-455-5p and PDZK1IP1 may therefore serve as key biomarkers and be involved in regulating partial EMT in OSCC cells. PDZK1IP1 expression may also serve as an independent factor that impacts outcomes in patients with clinical risk factors for recurrence.\n","tags":null,"title":"MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition","type":"publication"},{"authors":["Yi‚ÄëYing Wu","I-Shan Hsieh","*Chia-Hao Tung*","Chen-Hsun Weng","Jia‚ÄëEn Wu","Jau-Song Yu","Yuh‚ÄëLing Chen#","Tse‚ÄëMing Hong#"],"categories":null,"content":"","date":1646697600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1646697600,"objectID":"3a2783c0d7f649ed08991d6273e84ac2","permalink":"https://tungchuw.github.io/publication/2023-03-08-paper-annexina2/","publishdate":"2022-03-08T00:00:00Z","relpermalink":"/publication/2023-03-08-paper-annexina2/","section":"publication","summary":"Cancer remains one of the leading causes of death worldwide. Cancer stem cells (CSCs) are the underlying reason for tumor recurrence, progression, and therapeutic resistance. Aptamers are synthetic single-stranded oligonucleotides that can specifically bind to various molecular targets. Here, we aim to develop an effective aptamer-based biomarker and therapeutic tool that targets CSCs for cancer therapy. We perform whole-cell-based systematic evolution of ligands by exponential enrichment (cell-SELEX) to screen DNA aptamers that specifically bound to lung CSCs, modeled by E-cadherin-silenced A549 cells. We develop a CSC-specific aptamer (AP-9R) specifically recognizing lung CSCs with high affinity and identify Annexin A2, a Ca2+-dependent membrane-binding protein, as its target. Annexin A2 expression was upregulated in lung CSCs and involved in cancer stemness. The expression of Annexin A2 was associated with signatures of stemness and metastasis, as well as poor clinical outcomes, in lung cancer in silico. Moreover, AP-9R decreased Annexin A2 expression and suppressed CSC properties in CSCs in vitro and in vivo. The present findings suggest that Annexin A2 is a CSC marker and regulator, and the CSC-specific aptamer AP-9R has potential theranostic applications for lung cancer.","tags":null,"title":"A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2","type":"publication"},{"authors":["*Chia-Hao Tung*","Meng-Fan Huang","Chen-Hsien Liang","Yi-Ying Wu","Jia-En Wu","Cheng-Lung Hsu","Yuh-Ling Chen#","Tse-Ming Hong#"],"categories":null,"content":"","date":1640995200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1640995200,"objectID":"b31d53ee9a70a3b8853e1c11e6a3d154","permalink":"https://tungchuw.github.io/publication/2022-01-01-paper-catulin/","publishdate":"2022-01-01T00:00:00Z","relpermalink":"/publication/2022-01-01-paper-catulin/","section":"publication","summary":"**Background:**\nThe cytoskeletal linker protein Œ±-Catulin has been shown to be important for tumor progression in various cancers. However, its role in the regulation of cancer stemness remains unclear.\n**Methods:**\nPhenotypic effects of Œ±-Catulin on the cancer stem cell (CSC)-like properties and metastasis were examined by in vitro sphere formation assay, migration assay, invasion assay, and in vivo xenografted animal models. Yeast two-hybrid assay, co-immunoprecipitation assay, and cycloheximide chase assay were performed to confirm the effect of Œ±-Catulin on the WWP1-mediated degradation of KLF5. CPTAC and TCGA database were analyzed to determine the clinical association of Œ±-Catulin, KLF5, and stemness-associated signatures in lung adenocarcinoma.\n**Results:**\nWe report that Œ±-Catulin increases cancer stem-like properties in non-small cell lung cancer (NSCLC). The expression of Œ±-Catulin is elevated in tumor spheres compared to sphere-derived adherent cells and promotes the acquisition of cancer stemness characteristics in vitro and in vivo. Mechanistically, the interaction of Œ±-Catulin and the C-terminal region of Kruppel-like transcription factor KLF5 results in the inhibition of WWP1-mediated degradation of KLF5. Accordingly, increased protein expression of KLF5 is observed in clinical specimens of lung adenocarcinoma with high expression of Œ±-Catulin compared to specimens with low Œ±-Catulin-expression. Knockdown of KLF5 abrogates Œ±-Catulin-driven cancer stemness. Œ±-Catulin is known to interact with integrin-linked kinase (ILK). Notably, an ILK inhibitor disrupts the Œ±-Catulin-KLF5 interaction, promotes the degradation of KLF5, and decreases Œ±-Catulin-driven cancer stemness. Importantly, we identify a CTNNAL1/ILK/KLF5 three-gene signature for predicting poor overall survival in patients with lung adenocarcinoma.\n**Conclusions:**\nThese findings reveal a molecular basis of Œ±-Catulin-enhanced KLF5 signaling and highlight a role for Œ±-Catulin in promoting cancer stemness.\n","tags":null,"title":"Œ±-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer","type":"publication"},{"authors":["Chia-Hao Tung","Âê≥ÊÅ©ÈÅî"],"categories":["Demo","ÊïôÁ®ã"],"content":"import libr print(\u0026#39;hello\u0026#39;) Overview The Wowchemy website builder for Hugo, along with its starter templates, is designed for professional creators, educators, and teams/organizations - although it can be used to create any kind of site The template can be modified and customised to suit your needs. It‚Äôs a good platform for anyone looking to take control of their data and online identity whilst having the convenience to start off with a no-code solution (write in Markdown and customize with YAML parameters) and having flexibility to later add even deeper personalization with HTML and CSS You can work with all your favourite tools and apps with hundreds of plugins and integrations to speed up your workflows, interact with your readers, and much more Get Started üëâ Create a new site üìö Personalize your site üí¨ Chat with the Wowchemy community or Hugo community üê¶ Twitter: @wowchemy @GeorgeCushen #MadeWithWowchemy üí° Request a feature or report a bug for Wowchemy ‚¨ÜÔ∏è Updating Wowchemy? View the Update Tutorial and Release Notes Crowd-funded open-source software To help us develop this template and software sustainably under the MIT license, we ask all individuals and businesses that use it to help support its ongoing maintenance and development via sponsorship.\n‚ù§Ô∏è Click here to become a sponsor and help support Wowchemy‚Äôs future ‚ù§Ô∏è As a token of appreciation for sponsoring, you can unlock these awesome rewards and extra features ü¶Ñ‚ú®\nEcosystem Hugo Academic CLI: Automatically import publications from BibTeX Inspiration Check out the latest demo of what you‚Äôll get in less than 10 minutes, or view the showcase of personal, project, and business sites.\nFeatures Page builder - Create anything with widgets and elements Edit any type of content - Blog posts, publications, talks, slides, projects, and more! Create content in Markdown, Jupyter, or RStudio Plugin System - Fully customizable color and font themes Display Code and Math - Code highlighting and LaTeX math supported Integrations - Google Analytics, Disqus commenting, Maps, Contact Forms, and more! Beautiful Site - Simple and refreshing one page design Industry-Leading SEO - Help get your website found on search engines and social media Media Galleries - Display your images and videos with captions in a customizable gallery Mobile Friendly - Look amazing on every screen with a mobile friendly version of your site Multi-language - 34+ language packs including English, ‰∏≠Êñá, and Portugu√™s Multi-user - Each author gets their own profile page Privacy Pack - Assists with GDPR Stand Out - Bring your site to life with animation, parallax backgrounds, and scroll effects One-Click Deployment - No servers. No databases. Only files. Themes Wowchemy and its templates come with automatic day (light) and night (dark) mode built-in. Alternatively, visitors can choose their preferred mode - click the moon icon in the top right of the Demo to see it in action! Day/night mode can also be disabled by the site admin in params.toml.\nChoose a stunning theme and font for your site. Themes are fully customizable.\nLicense Copyright 2016-present George Cushen.\nReleased under the MIT license.\n","date":1607817600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1607817600,"objectID":"279b9966ca9cf3121ce924dca452bb1c","permalink":"https://tungchuw.github.io/post/getting-started/","publishdate":"2020-12-13T00:00:00Z","relpermalink":"/post/getting-started/","section":"post","summary":"Welcome üëã We know that first impressions are important, so we've populated your new site with some initial content to help you get familiar with everything in no time.","tags":["Academic","ÂºÄÊ∫ê"],"title":"Welcome to Hugo Blox Builder, the website builder for Hugo","type":"post"},{"authors":["Jia-En Wu","Yi-Ying Wu","*Chia-Hao Tung*","Yao-Tsung Tsai","Hsuan-Yu Chen","Yuh-Ling Chen#","Tse-Ming Hong#"],"categories":null,"content":"","date":1594425600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1594425600,"objectID":"9764761da3f8c954bd8bb31c9c75b006","permalink":"https://tungchuw.github.io/publication/2020-07-11-paper-cldn1/","publishdate":"2020-07-11T00:00:00Z","relpermalink":"/publication/2020-07-11-paper-cldn1/","section":"publication","summary":"**Background:**\nThe loss of cancer-cell junctions and escape from the primary-tumor microenvironment are hallmarks of metastasis. A tight-junction protein, Claudin 1 (CLDN1), is a metastasis suppressor in lung adenocarcinoma. However, as a metastasis suppressor, the underlying molecular mechanisms of CLDN1 has not been well studied.\n**Methods:**\nThe signaling pathway regulated by CLDN1 was analyzed by Metacore software and validated by immunoblots. The effect of the CLDN1-EPHB6-ERK-SLUG axis on the formation of cancer stem-like cells, drug resistance and metastasis were evaluated by sphere assay, aldefluor assay, flow cytometry, migration assay, cytotoxicity, soft agar assay, immunoprecipitation assay and xenograft experiments. Furthermore, the methylation-specific PCR, pyrosequencing assay, chromatin immunoprecipitation and reporter assay were used to study the epigenetic and RUNX3-mediated CLDN1 transcription. Finally, the molecular signatures of RUNX3/CLDN1/SLUG were used to evaluate the correlation with overall survival by using gene expression omnibus (GEO) data.\n**Results:**\nWe demonstrated that CLDN1 repressed cancer progression via a feedback loop of the CLDN1-EPHB6-ERK1/2-SLUG axis, which repressed metastasis, drug resistance, and cancer stemness, indicating that CLDN1 acts as a metastasis suppressor. CLDN1 upregulated the cellular level of EPHB6 and enhanced its activation, resulting in suppression of ERK1/2 signaling. Interestingly, DNA hypermethylation of the CLDN1 promoter abrogated SLUG-mediated suppression of CLDN1 in low-metastatic cancer cells. In contrast, the histone deacetylase inhibitor trichostatin A or vorinostat facilitated CLDN1 expression in high-metastatic cancer cells and thus increased the efficacy of chemotherapy. Combined treatment with cisplatin and trichostatin A or vorinostat had a synergistic effect on cancer-cell death.\n**Conclusions:**\nThis study revealed that DNA methylation maintains CLDN1 expression and then represses lung cancer progression via the CLDN1-EPHB6-ERK1/2-SLUG axis. Because CLDN1 enhances the efficacy of chemotherapy, CLDN1 is not only a prognostic marker but a predictive marker for lung adenocarcinoma patients who are good candidates for chemotherapy. Forced CLDN1 expression in low CLDN1-expressing lung adenocarcinoma will increase the chemotherapy response, providing a novel therapeutic strategy.\n","tags":null,"title":"DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression","type":"publication"},{"authors":["Yao-Tsung Tsai","Chen-Hsien Liang","Jin-Hsuan Yu","Kuan-Chih Huang","*Chia-Hao Tung*","Jia-En Wu","Yi-Ying Wu","Chih-Hsien Chang","Tse-Ming Hong#","Yuh-Ling Chen#"],"categories":null,"content":"","date":1575590400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1575590400,"objectID":"260a41717aa149026a0cd69b36a667d6","permalink":"https://tungchuw.github.io/publication/2019-12-06-paper-gal1/","publishdate":"2019-12-06T00:00:00Z","relpermalink":"/publication/2019-12-06-paper-gal1/","section":"publication","summary":"Galectin-1 (Gal-1) is a pleiotropic homodimeric Œ≤-galactoside-binding protein with a single carbohydrate recognition domain. It has been implicated in several biological processes that are important during tumor progression. Several lines of evidence have indicated that Gal-1 is involved in cancer immune escape and induces T cell apoptosis. These observations all emphasized Gal-1 as a novel target for cancer immunotherapy. Here, we developed a novel Gal-1-targeting DNA aptamer (AP-74 M-545) and demonstrated its antitumor effect by restoring immune function. AP-74 M-545 binds to Gal-1 with high affinity. AP-74 M-545 targets tumors in murine tumor models but suppresses tumor growth only in immunocompetent C57BL/6 mice, not in immunocompromised non-obese diabetic (NOD)/severe combined immunodeficiency (SCID) mice. Immunohistochemistry revealed increased CD4+ and CD8+ T cells in AP-74 M-545-treated tumor tissues. AP-74 M-545 suppresses T cell apoptosis by blocking the binding of Gal-1 to CD45, the main receptor and apoptosis mediator of Gal-1 on T cells. Collectively, our data suggest that the Gal-1 aptamer suppresses tumor growth by blocking the interaction between Gal-1 and CD45 to rescue T cells from apoptosis and restores T cell-mediated immunity. These results indicate that AP-74 M-545 may be a potential strategy for cancer immunotherapy.","tags":null,"title":"A DNA Aptamer targeting galectin-1 as a novel immunotherapeutic strategy for lung cancer","type":"publication"},{"authors":["*Chia-Hao Tung*","Meng-Fan Huang","Li-Wei Kuo","Yi-Ying Wu","Yao-Tsung Tsai","Jia-En Wu","Keng-Fu Hsu","Yuh-Ling Chen#","Tse-Ming Hong#"],"categories":null,"content":"","date":1569801600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569801600,"objectID":"49939d87e2bae364627a2c2cc572ae9a","permalink":"https://tungchuw.github.io/publication/2019-09-30-paper-mir150/","publishdate":"2019-09-30T00:00:00Z","relpermalink":"/publication/2019-09-30-paper-mir150/","section":"publication","summary":"Treatment of ovarian cancer (OvCa) remains challenging owing to its high recurrence rates. Detachment of cancer cells into the peritoneal fluid plays a key role in OvCa relapse, but how this occurs remains incompletely understood. Here we examined global miRNA expression profiles of paired primary/recurrent OvCa specimens and identified a novel biomarker, microRNA-150-5p (miR-150-5p), that was significantly upregulated in 16 recurrent OvCa tissues compared with their matched primary specimens. Analyses of cohorts from two other groups confirmed that expression of miR-150-5p was associated with early relapse and poor survival of OvCa patients. Inhibition of miR-150-5p significantly inhibited the migration and invasion of OvCa cells and induced a mesenchymal-epithelial transition (MET) phenotype. We demonstrated that the proto-oncogene, MYB, is an miR-150-5p target in OvCa cells and that the miR-150-5p/c-Myb/Slug axis plays important roles in regulating epithelial-mesenchymal transition (EMT) in OvCa cells. Expression of MYB was significantly correlated with good clinical outcome in OvCa and was negatively correlated with Slug expression in late-stage clinical specimens. These results suggest that miR-150-5p upregulation mediates the progression of recurrent OvCa by targeting the c-Myb/Slug pathway. Inhibition of miR-150-5p may serve as a new therapeutic strategy for preventing recurrence of OvCa.","tags":null,"title":"MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer","type":"publication"},{"authors":null,"categories":null,"content":"Hugo Blox Builder is designed to give technical content creators a seamless experience. You can focus on the content and Wowchemy handles the rest.\nHighlight your code snippets, take notes on math classes, and draw diagrams from textual representation.\nOn this page, you‚Äôll find some examples of the types of technical content that can be rendered with Wowchemy.\nExamples Code Wowchemy supports a Markdown extension for highlighting code syntax. You can customize the styles under the syntax_highlighter option in your config/_default/params.yaml file.\n```python import pandas as pd data = pd.read_csv(\u0026#34;data.csv\u0026#34;) data.head() ``` renders as\nimport pandas as pd data = pd.read_csv(\u0026#34;data.csv\u0026#34;) data.head() Mindmaps Wowchemy supports a Markdown extension for mindmaps.\nSimply insert a Markdown markmap code block and optionally set the height of the mindmap as shown in the example below.\nA simple mindmap defined as a Markdown list:\n```markmap {height=\u0026#34;200px\u0026#34;} - Hugo Modules - wowchemy - blox-plugins-netlify - blox-plugins-netlify-cms - blox-plugins-reveal ``` renders as\n- Hugo Modules - wowchemy - blox-plugins-netlify - blox-plugins-netlify-cms - blox-plugins-reveal A more advanced mindmap with formatting, code blocks, and math:\n```markmap - Mindmaps - Links - [Wowchemy Docs](https://docs.hugoblox.com/) - [Discord Community](https://discord.gg/z8wNYzb) - [GitHub](https://github.com/HugoBlox/hugo-blox-builder) - Features - Markdown formatting - **inline** ~~text~~ *styles* - multiline text - `inline code` - ```js console.log(\u0026#39;hello\u0026#39;); console.log(\u0026#39;code block\u0026#39;); ``` - Math: $x = {-b \\pm \\sqrt{b^2-4ac} \\over 2a}$ ``` renders as\n- Mindmaps - Links - [Wowchemy Docs](https://docs.hugoblox.com/) - [Discord Community](https://discord.gg/z8wNYzb) - [GitHub](https://github.com/HugoBlox/hugo-blox-builder) - Features - Markdown formatting - **inline** ~~text~~ *styles* - multiline text - `inline code` - ```js console.log(\u0026#39;hello\u0026#39;); console.log(\u0026#39;code block\u0026#39;); ``` - Math: $x = {-b \\pm \\sqrt{b^2-4ac} \\over 2a}$ Charts Wowchemy supports the popular Plotly format for interactive charts.\nSave your Plotly JSON in your page folder, for example line-chart.json, and then add the {{\u0026lt; chart data=\u0026#34;line-chart\u0026#34; \u0026gt;}} shortcode where you would like the chart to appear.\nDemo:\nYou might also find the Plotly JSON Editor useful.\nMath Wowchemy supports a Markdown extension for $\\LaTeX$ math. You can enable this feature by toggling the math option in your config/_default/params.yaml file.\nTo render inline or block math, wrap your LaTeX math with {{\u0026lt; math \u0026gt;}}$...${{\u0026lt; /math \u0026gt;}} or {{\u0026lt; math \u0026gt;}}$$...$${{\u0026lt; /math \u0026gt;}}, respectively. (We wrap the LaTeX math in the Wowchemy math shortcode to prevent Hugo rendering our math as Markdown. The math shortcode is new in v5.5-dev.)\nExample math block:\n{{\u0026lt; math \u0026gt;}} $$ \\gamma_{n} = \\frac{ \\left | \\left (\\mathbf x_{n} - \\mathbf x_{n-1} \\right )^T \\left [\\nabla F (\\mathbf x_{n}) - \\nabla F (\\mathbf x_{n-1}) \\right ] \\right |}{\\left \\|\\nabla F(\\mathbf{x}_{n}) - \\nabla F(\\mathbf{x}_{n-1}) \\right \\|^2} $$ {{\u0026lt; /math \u0026gt;}} renders as\n$$\\gamma_{n} = \\frac{ \\left | \\left (\\mathbf x_{n} - \\mathbf x_{n-1} \\right )^T \\left [\\nabla F (\\mathbf x_{n}) - \\nabla F (\\mathbf x_{n-1}) \\right ] \\right |}{\\left \\|\\nabla F(\\mathbf{x}_{n}) - \\nabla F(\\mathbf{x}_{n-1}) \\right \\|^2}$$ Example inline math {{\u0026lt; math \u0026gt;}}$\\nabla F(\\mathbf{x}_{n})${{\u0026lt; /math \u0026gt;}} renders as $\\nabla F(\\mathbf{x}_{n})$.\nExample multi-line math using the math linebreak (\\\\):\n{{\u0026lt; math \u0026gt;}} $$f(k;p_{0}^{*}) = \\begin{cases}p_{0}^{*} \u0026amp; \\text{if }k=1, \\\\ 1-p_{0}^{*} \u0026amp; \\text{if }k=0.\\end{cases}$$ {{\u0026lt; /math \u0026gt;}} renders as\n$$ f(k;p_{0}^{*}) = \\begin{cases}p_{0}^{*} \u0026amp; \\text{if }k=1, \\\\ 1-p_{0}^{*} \u0026amp; \\text{if }k=0.\\end{cases} $$ Diagrams Wowchemy supports a Markdown extension for diagrams. You can enable this feature by toggling the diagram option in your config/_default/params.toml file or by adding diagram: true to your page front matter.\nAn example flowchart:\n```mermaid graph TD A[Hard] --\u0026gt;|Text| B(Round) B --\u0026gt; C{Decision} C --\u0026gt;|One| D[Result 1] C --\u0026gt;|Two| E[Result 2] ``` renders as\ngraph TD A[Hard] --\u0026gt;|Text| B(Round) B --\u0026gt; C{Decision} C --\u0026gt;|One| D[Result 1] C --\u0026gt;|Two| E[Result 2] An example sequence diagram:\n```mermaid sequenceDiagram Alice-\u0026gt;\u0026gt;John: Hello John, how are you? loop Healthcheck John-\u0026gt;\u0026gt;John: Fight against hypochondria end Note right of John: Rational thoughts! John--\u0026gt;\u0026gt;Alice: Great! John-\u0026gt;\u0026gt;Bob: How about you? Bob--\u0026gt;\u0026gt;John: Jolly good! ``` renders as\nsequenceDiagram Alice-\u0026gt;\u0026gt;John: Hello John, how are you? loop Healthcheck John-\u0026gt;\u0026gt;John: Fight against hypochondria end Note right of John: Rational thoughts! John--\u0026gt;\u0026gt;Alice: Great! John-\u0026gt;\u0026gt;Bob: How about you? Bob--\u0026gt;\u0026gt;John: Jolly good! An example Gantt diagram:\n```mermaid gantt section Section Completed :done, des1, 2014-01-06,2014-01-08 Active :active, des2, 2014-01-07, 3d Parallel 1 : des3, after des1, 1d Parallel 2 : des4, after des1, 1d Parallel 3 : des5, after des3, 1d Parallel 4 : des6, after des4, 1d ``` renders as\ngantt section ‚Ä¶","date":1562889600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1562889600,"objectID":"07e02bccc368a192a0c76c44918396c3","permalink":"https://tungchuw.github.io/post/writing-technical-content/","publishdate":"2019-07-12T00:00:00Z","relpermalink":"/post/writing-technical-content/","section":"post","summary":"Hugo Blox Builder is designed to give technical content creators a seamless experience. You can focus on the content and Wowchemy handles the rest.\nHighlight your code snippets, take notes on math classes, and draw diagrams from textual representation.","tags":null,"title":"Writing technical content in Markdown","type":"post"},{"authors":[],"categories":[],"content":"Create slides in Markdown with Hugo Blox Builder Hugo Blox Builder | Documentation\nFeatures Efficiently write slides in Markdown 3-in-1: Create, Present, and Publish your slides Supports speaker notes Mobile friendly slides Controls Next: Right Arrow or Space Previous: Left Arrow Start: Home Finish: End Overview: Esc Speaker notes: S Fullscreen: F Zoom: Alt + Click PDF Export Code Highlighting Inline code: variable\nCode block:\nporridge = \u0026#34;blueberry\u0026#34; if porridge == \u0026#34;blueberry\u0026#34;: print(\u0026#34;Eating...\u0026#34;) Math In-line math: $x + y = z$\nBlock math:\n$$ f\\left( x \\right) = ;\\frac{{2\\left( {x + 4} \\right)\\left( {x - 4} \\right)}}{{\\left( {x + 4} \\right)\\left( {x + 1} \\right)}} $$\nFragments Make content appear incrementally\n{{% fragment %}} One {{% /fragment %}} {{% fragment %}} **Two** {{% /fragment %}} {{% fragment %}} Three {{% /fragment %}} Press Space to play!\nOne Two Three A fragment can accept two optional parameters:\nclass: use a custom style (requires definition in custom CSS) weight: sets the order in which a fragment appears Speaker Notes Add speaker notes to your presentation\n{{% speaker_note %}} - Only the speaker can read these notes - Press `S` key to view {{% /speaker_note %}} Press the S key to view the speaker notes!\nOnly the speaker can read these notes Press S key to view Themes black: Black background, white text, blue links (default) white: White background, black text, blue links league: Gray background, white text, blue links beige: Beige background, dark text, brown links sky: Blue background, thin dark text, blue links night: Black background, thick white text, orange links serif: Cappuccino background, gray text, brown links simple: White background, black text, blue links solarized: Cream-colored background, dark green text, blue links Custom Slide Customize the slide style and background\n{{\u0026lt; slide background-image=\u0026#34;/media/boards.jpg\u0026#34; \u0026gt;}} {{\u0026lt; slide background-color=\u0026#34;#0000FF\u0026#34; \u0026gt;}} {{\u0026lt; slide class=\u0026#34;my-style\u0026#34; \u0026gt;}} Custom CSS Example Let‚Äôs make headers navy colored.\nCreate assets/css/reveal_custom.css with:\n.reveal section h1, .reveal section h2, .reveal section h3 { color: navy; } Questions? Ask\nDocumentation\n","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549324800,"objectID":"0e6de1a61aa83269ff13324f3167c1a9","permalink":"https://tungchuw.github.io/slides/example/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/slides/example/","section":"slides","summary":"An introduction to using Hugo Blox Builder's Slides feature.","tags":[],"title":"Slides","type":"slides"},{"authors":["Yi-Ying Wu","Chia-Lin Chang","Yuan-Jhe Chuang","Jia-En Wu","*Chia-Hao Tung*","Yeong-Chang Chen","Yuh-Ling Chen","Tse-Ming Hong","Keng-Fu Hsu#"],"categories":null,"content":"","date":1464739200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1464739200,"objectID":"40570f0ecec97f2a70d797625e6f99d5","permalink":"https://tungchuw.github.io/publication/2016-06-01-paper-casz1/","publishdate":"2016-06-01T00:00:00Z","relpermalink":"/publication/2016-06-01-paper-casz1/","section":"publication","summary":"Epithelial ovarian cancer (EOC) carries the highest mortality rate of all gynecologic malignancies. This high mortality rate is attributed to the fact that most cases of ovarian cancer are detected at late stages when metastases are already present. Through microarray analysis, we previously demonstrated that castor zinc finger 1 (CASZ1) is up-regulated in EOC cells. In contrast to its role in EOC, CASZ1 functions a tumor suppressor in neuroblastoma. Human CASZ1 is predominantly expressed in 2 alternatively spliced isoforms: CASZ1a and CASZ1b. In the present study, we investigated the role of CASZ1 in ovarian cancer cell migration and invasion and assessed the value of CASZ1 expression as a prognostic indicator of metastasis in human ovarian cancer. We used a lentivirus expressing CASZ1-shRNA and a plasmid expressing CASZ1 from a CMV promoter to knockdown and overexpress CASZ1, respectively, in the MCAS, RMUG-S, TOV21G, and A2780CP70 ovarian cancer cell lines. mRNA expression levels in tumor tissues and cell lines were measured using quantitative real-time PCR, and CASZ1 protein expression in EOC and paired metastatic tumor tissues was analyzed using immunohistochemistry. We found that CASZ1 was highly expressed in EOC tissues and ovarian cancer cell lines and that CASZ1 knockdown suppressed cell migration and invasion in EOC cells. CASZ1a and CASZ1b exerted similar effects on cell migration and invasion in EOC cells. In addition, CASZ1 promoted the epithelial-mesenchymal transition in EOC cells, and CASZ1 knockdown suppressed cancer metastasis in vivo. Furthermore, CASZ1 protein levels were elevated in human metastatic ovarian tumor tissues. Together, these results indicate that CASZ1 is a novel promoter of EOC metastasis and is highly up-regulated in metastatic EOC tumors.","tags":null,"title":"CASZ1 is a novel promoter of metastasis in ovarian cancer","type":"publication"},{"authors":null,"categories":null,"content":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"e8f8d235e8e7f2efd912bfe865363fc3","permalink":"https://tungchuw.github.io/project/example/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/example/","section":"project","summary":"An example of using the in-built project page.","tags":["Deep Learning"],"title":"Example Project","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"d1311ddf745551c9e117aa4bb7e28516","permalink":"https://tungchuw.github.io/project/external-project/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/external-project/","section":"project","summary":"An example of linking directly to an external project website using `external_link`.","tags":["Demo"],"title":"External Project","type":"project"}]